May 14, 2002 Dear Pharmacy Professional, We would like to call to your attention a situation involving counterfeit labeling of Combivir� (lamivudine plus zidovudine) Tablets. GlaxoSmithKline has received four reports o

First Page		Document Content
Medicine Cyclopropanes Abacavir Purines Organofluorides Lamivudine GlaxoSmithKline Zidovudine Fixed dose combination Chemistry Pharmacology		May 14, 2002 Dear Pharmacy Professional, We would like to call to your attention a situation involving counterfeit labeling of Combivir� (lamivudine plus zidovudine) Tablets. GlaxoSmithKline has received four reports o Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 16,24 KB Share Document on Facebook

	PDF Document DocID: 1xvUb - View Document
	PDF Document DocID: 1xc8R - View Document
	Institute of Pharmacology www.pki.unibe.ch Introduction Prof. Dr. Dr. Stephan von Gunten MD PhD MME DocID: 1vqsj - View Document
	Jansone et al.: Intrinsic Activity, 2017; 5 (Suppl.2):A1.6 doi:IA.5.S2-A1.6 published online: 16 October 2017 2nd International Conference in Pharmacology: From Cellular Processes to Drug Targets Rīga, Latvia DocID: 1vlJU - View Document
	Human cells Notable for research in: -Medecine: Diseases and cancers -Cell Biology -Pharmacology DocID: 1vk1K - View Document